KEGG pathway enrichment was primarily observed in pathways such as basal cell carcinoma (hsa05217), breast cancer (hsa05224), motor proteins (hsa04814), and the thyroid hormone signaling pathway (hsa04919). This evidence concerns the gene TG and breast carcinoma.